Leukemoid Reaction in an Elderly Patient with Aortic Valve Infective Endocarditis and Pancreatic Adenocarcinoma

Leukemoid reaction (LR) associated with solid tumors has been documented for many decades. LR is often associated with an unfavorable prognosis and aggressive course of the disease. However, the differential diagnosis of LR is of significant difficulty when a patient has several potential etiological factors, each of them individually may cause LR or, on the contrary, lead to a systemic reaction of the body within a single pathogenetic chain.

We present a clinical observation of an elderly patient admitted to the intensive care unit due to the first-time encountered weakness in the right extremities. Clinical and instrumental examination revealed an acute cerebral ischemia with leukocytosis increase up to 60.000 cells/μL with leukocyte formula left shift and subsequent patient decompensation with lethal outcome, despite the intensive treatment.

Autopsy revealed a low-differentiated adenocarcinoma of the pancreatic tail with multiple metastatic lesions in regional lymph nodes and liver, as well as a competing disease — acute infective endocarditis of the aortic valve, which was the cause of sepsis development with septicemia type and thromboembolism both in the great circulation circle with the presence of ischemic cerebral infarction, spleen infarcts, and in the small circle with the development of thromboembolism in the right segmental branches of the pulmonary artery. Given the advanced stage of pancreatic cancer and lack of direct evidence of sepsis at primary diagnosis, paraneoplastic nature of LR is more likely, but infective endocarditis and concomitant pathology also may have contributed to the development of LR.

1. Abukhiran I., Mott S.L., Bellizzi A.M. et al. Paraneoplastic leukemoid reaction: Case report and review of the literature. Pathol Res Pract. 2021; 217: 153295. doi: 10.1016/j.prp.2020.153295

2. Chesnokova N.P., Nevvazhai T.A., Ponukalina E.V. et al. Leukemoid reactions: classification, etiology, pathogenesis, fundamental differences from leukemia. Mezhdunarodnyi zhurnal eksperimental’nogo obrazovaniya. 2015; 7: 186-188. [in Russian]

3. Karakonstantis S., Koulouridi M., Pitsillos K. et al. A prospective study of hospitalized patients with leukemoid reaction; causes, prognosis and value of manual peripheral smear review. Rom J Intern Med. 2019; 57(3): 241-247. doi: 10.2478/rjim-2019-0006

4. Chakraborty S., Keenportz B., Woodward S. et al. Paraneoplastic leukemoid reaction in solid tumors. Am J Clin Oncol. 2015; 38(3): 326-330. doi: 10.1097/COC.0b013e3182a530dd

5. Abukhiran I.A., Jasser J., Syrbu S. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. J Clin Pathol. 2020; 73(6): 310-313. doi: 10.1136/jclinpath-2019-206340

6. Granger J.M., Kontoyiannis D.P. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer. 2009; 115(17): 3919-3923. doi: 10.1002/cncr.24480

7. Quintero-Martinez JA, Hindy JR, El Zein S, et al. Contemporary demographics, diagnostics and outcomes in non-bacterial thrombotic endocarditis. Heart. 2022; heartjnl-2022-320970. doi: 10.1136/heartjnl-2022-320970

8. Bussani R, DE-Giorgio F, Pesel G, et al. Overview and Comparison of Infectious Endocarditis and Non-infectious Endocarditis: A Review of 814 Autoptic Cases. In Vivo. 2019; 33(5): 1565-1572. doi: 10.21873/invivo.11638

9. Itzhaki B.O., Spectre G., Leader A. Cancer-associated non-bacterial thrombotic endocarditis. Thromb Res. 2022;213 Suppl 1: S127-S132. doi: 10.1016/j.thromres.2021.11.024

10. Kabashneh S., Ali H., Shanah L. et al. Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma. Cureus. 2020; 12(7): e9013. doi: 10.7759/cureus.9013

11. Sánchez-Enrique C., Vilacosta I., Moreno H.G. et al. Infected marantic endocarditis with leukemoid reaction. Circ J. 2014; 78(9): 2325-2327. doi: 10.1253/circj.cj-14-0079

12. Dos Santos M., Bouhier K., Dao M.T. Paraneoplastic leukemoid reaction in pancreatic cancer: A case report. World J Gastrointest Oncol. 2015; 7(10): 259-262. doi: 10.4251/wjgo.v7.i10.259

13. Sakka V., Tsiodras S., Giamarellos-Bourboulis E.J. et al. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006; 17(6): 394-398. doi: 10.1016/j.ejim.2006.04.004

14. McCoach C.E., Rogers J.G., Dwyre D.M. et al. Paraneoplastic Leukemoid Reaction as a Marker of Tumor Progression in Non-Small Cell Lung Cancer. Cancer Treat Commun. 2015; 4: 15-18. DOI: 10.1016/j.ctrc.2015.03.003

15. Portich J.P., Faulhaber GAM. Leukemoid reaction: A 21st-century cohort study. Int J Lab Hematol. 2020; 42(2): 134-139. DOI: 10.1111/ijlh.13127

16. Potasman I, Grupper M. Leukemoid reaction: spectrum and prognosis of 173 adult patients. Clin Infect Dis. 2013; 57(11): e177-e181. DOI: 10.1093/cid/cit562

17. Au WY, Ma SK, Kwong YL. Disseminated hepatosplenic mycobacterial infection masking myeloproliferative diseases as leukemoid reaction: a diagnostic pitfall. Leuk Lymphoma. 2001; 42(4): 805-808. DOI: 10.3109/10428190109099344

18. Naaraayan A., Aleta M., Basak P. et al. Leukemoid reaction to Clostridium difficile infection. Anaerobe. 2015; 34: 158-160. DOI: 10.1016/j.anaerobe.2015.05.005

19. Marinella M.A., Burdette S.D., Bedimo R. et al. Leukemoid reactions complicating colitis due to Clostridium difficile. South Med J. 2004; 97(10): 959-963. DOI: 10.1097/01.SMJ.0000054537.20978.D4

20. Tarekegn K, Colon Ramos A, Sequeira Gross HG, Yu M, Fulger I. Leukemoid Reaction in a Patient With Severe COVID-19 Infection. Cureus. 2021; 13(2): e13598. DOI: 10.7759/cureus.13598